Press Releases

AIRE is an Artificial Intelligence platform that automatically accessions cases and provides significant improvements in accuracy and efficiency  July 14, 2022 – Spokane, WA. Gestalt Diagnostics, Inc., a leading provider of digital pathology solutions, announces the availability of their Artificial Intelligence Requisition Engine (AIRE). AIRE drastically improves speed and accuracy over time-consuming, manual data entry tasks. It […]

Gestalt-Hamamatsu unified solution will provide end-to-end support to the entire workflow. June 7, 2022 – Spokane, WA. Today, Gestalt Diagnostics, Inc., a leading provider of digital pathology solutions, and Hamamatsu Photonics K.K., a leading provider of whole slide imaging systems, announced the implementation of a unified solution at Intermountain Healthcare. This combined solution will facilitate Intermountain

May 19, 2022 – Spokane, WA. Leading provider of digital pathology solutions, Gestalt Diagnostics, Inc today announces the re-launch of its website with embedded user-triggered accessibility functions. This functionality features new ways for users with disabilities to navigate, connect, and access Gestalt’s solutions and website in the way that is most beneficial for them. At

How do they differ from the older, classic rules-based algorithms? Before we get started, let’s look at the background on terminology. The older, classic algorithms that we all know and love are rules based, classical computer vision algorithms. However, when most people say AI now, they are often referring to Deep Learning. Deep Learning, also

Spokane, WA, (October 18, 2021) – Gestalt Diagnostics will be debuting the newest version of PathFlow®, our award winning digital pathology solution during DPA’s Pathology Visions Conference in Las Vegas, NV October 17-20, 2021. “We are excited to be announcing the latest release of PathFlow” says Gestalt’s COO & Chief Strategy Officer, Lisa-Jean Clifford. “The technology

“Pathology, as the bridge between science and medicine, plays a pivotal role in healthcare, from aiding diagnostic assessment to providing treatment insights.”    Read more.

The entire healthcare community is painfully aware of the impact that the COVID-19 pandemic has had on patients, staff, healthcare facilities, capacity, and supplies. The effect on laboratories has been two-fold.  Read the full article.

Spokane, WA, (September 8, 2021) – Gestalt Diagnostics has been named in the Top 10 Healthcare Workflow Solution Providers for 2021 by Healthcare Tech Outlook Magazine.   Healthcare Tech Outlook publishes an annual listing of the Top 10 companies that are at the forefront of solving healthcare workflow challenges who have a direct impact through technology.

Spokane, WA, and Seoul, Korea (July 14, 2021) – Gestalt Diagnostics and Deep Bio today announced their strategic relationship on the development of an integrated workflow for pathologists to use Artificial Intelligence algorithms directly within Gestalt’s PathFlow® platform. Deep Bio’s algorithm analyzes whole slide images (WSIs) of H&E-stained prostate core needle biopsy tissue specimens to detect and

Gestalt has been named in the Top 10 Solution Providers for workflow applications by CIO Applications. CIO publishes an annual listing of the Top 10 companies that are atthe forefront of providing workflow solutions that transform businesses. “We are excited to be named a Top 10 workflow solution provider in this annual listing” says Gestalt’s